15/04/2024

News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History

15/04/2024

Apr 15, 2024, 16:02 | Positive
Sumanta Pal: Meet the youngest SWOG Cancer Research Network members
Sumanta Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared on…
Apr 15, 2024, 15:55 | Blog
Jennifer Plichta: My favorite speaker Mike Dixon never disappoints!
Jennifer Plichta, Director of the Breast Risk Assessment Clinic at Duke University Health System, shared…
Apr 15, 2024, 14:41 | Drugs
Piotr Wysocki: The [177Lu]Lu-PSMA-617 plus enzalutamide combination is active and safe in mCRPC patients, but is it really an option for first-line treatment?
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 15, 2024, 14:38 | Insight
New Paper Alert! Refining Treatment Approaches in Early Breast Cancer Patients with Pathologic Complete Response
Refining Treatment Approaches in Early Breast Cancer Patients with Pathologic Complete Response Authors: Carmine Valenza,…
Apr 15, 2024, 14:36 | Insight
Patrick Hwu: What is pyroptosis and how can it activate an antitumor immune response?
Patrick Hwu, President and CEO at Moffit Cancer Center, shared on X/Twitter: "What is pyroptosis…
Apr 15, 2024, 14:01 | Insight
New Paper Alert! How Tumor Biomechanics Shape Metastatic Dissemination of Triple Negative Breast Cancer
How Tumor Biomechanics Shape Metastatic Dissemination of Triple Negative Breast Cancer Authors: Elysse C. Filipe,*…
Apr 15, 2024, 13:41 | Blog
Angela Mastronuzzi: New evidence in the integrated management of neuro-oncology adult and pediatric patients
Angela Mastronuzzi shared on LinkedIn: “‘New evidence in the integrated management of neuro-oncology adult and pediatric…
Apr 15, 2024, 13:36 | Opinion
Roupen Odabashian: Writing medical notes is very subjective: Some AI scribe can help
Roupen Odabashian shared a post on LinkedIn: ''I remember in residency, I spent the first two…
Apr 15, 2024, 13:34 | Insight
New Paper Alert! Addressing Postprogression Therapy Confounding in Phase III Oncology Trials: A Crucial Step for Accurate Overall Survival Estimates
Addressing Postprogression Therapy Confounding in Phase III Oncology Trials: A Crucial Step for Accurate Overall…
Apr 15, 2024, 13:28 | Insight
Antonio Passaro: Release of our editorial, co-authored with Peters Solange, focusing on the groundbreaking ALINA study
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared on LinkedIn: ''I am thrilled…
All: 81 Posts: 21 - 30